Elevated interferon gamma expression in the central nervous system of tumour necrosis factor receptor 1‐deficient mice with experimental autoimmune encephalomyelitis
Open Access
- 10 July 2006
- journal article
- Published by Wiley in Immunology
- Vol. 118 (4) , 527-538
- https://doi.org/10.1111/j.1365-2567.2006.02395.x
Abstract
Inflammation in the central nervous system (CNS) can be studied in experimental autoimmune encephalomyelitis (EAE). The proinflammatory cytokines interferon-gamma (IFN-γ) and tumour necrosis factor (TNF) are implicated in EAE pathogenesis. Signals through the type 1 TNF receptor (TNFR1) are required for severe EAE to develop, whereas deficiency in IFN-γ or its receptor result in more severe EAE. We investigated IFN-γ expression in TNFR1-deficient (TNFR1–/–) mice. We describe here that there were more IFN-γ-secreting T cells present in the CNS of TNFR1–/– mice during EAE compared to wild-type (WT) mice, despite that clinical symptoms were mild, with delayed onset. There was greater expression of IL-12/23p40 by antigen-presenting cells in these mice, and in vitro, TNFR1–/– antigen-presenting cells induced greater secretion of IFN-γ but not interleukin (IL)-17 when cultured with primed T cells than did WT antigen presenting cells. TNFR1–/– mice with EAE had significantly higher expression of CXCL10 mRNA (but not CCL5 mRNA) in the CNS compared to WT mice with EAE. These data demonstrate that IFN-γ expression is enhanced in the CNS of TNFR1–/– mice with EAE and suggest that IFN-γ levels do not necessarily correlate with EAE severity.Keywords
This publication has 63 references indexed in Scilit:
- Cytokine, chemokine and growth factor gene profiling of cultured human astrocytes after exposure to proinflammatory stimuliGlia, 2003
- Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brainNature, 2003
- Interleukin-12 and the regulation of innate resistance and adaptive immunityNature Reviews Immunology, 2003
- Tumour necrosis factor-alpha and lymphotoxin-alpha in the pathology of experimental autoimmune encephalomyelitis: is either one responsible or is there another ligand-mediating disease?Research in Immunology, 1998
- Tumor necrosis factor blockade in actively induced experimental autoimmune encephalomyelitis prevents clinical disease despite activated T cell infiltration to the central nervous systemEuropean Journal of Immunology, 1997
- TNF-α receptor fusion protein prevents experimental auto-immune encephalomyelitis and demyelination in Lewis rats: an overviewJournal of Neuroimmunology, 1997
- The IL-12 p40 homodimer as a specific antagonist of the IL-12 heterodimerImmunology Today, 1995
- Effect of anti-interferon-γ monoclonal antibody treatment on the development of experimental allergic encephalomyelitis in resistant mouse strainsPublished by Elsevier ,1994
- Lymphokines and immunoregulatory molecules in subacute sclerosing panencephalitisClinical Immunology and Immunopathology, 1991
- Multiple Sclerosis: Distribution of T Cell Subsets Within Active Chronic LesionsScience, 1983